BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publication
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Balaxi Pharmaceuticals has published a newspaper advertisement informing shareholders about a special window for transferring and dematerialising physical shares. The window, open from February 5, 2026 to February 4, 2027, is pursuant to SEBI's January 30, 2026 circular. Shareholders who hold physical shares purchased or sold before April 1, 2019 can now lodge fresh transfer requests or re-lodge previously rejected/returned requests. The transferred securities will be credited only in demat mode and will be locked in for one year. Requests involving disputes or pending litigation will not be processed. Shareholders must submit original share certificates, transfer deeds, and required documents to the company's RTA, Aarthi Consultants Private Limited.
This is a routine regulatory compliance filing with no direct impact on Balaxi Pharma's business operations or stock price. It provides an administrative opportunity for shareholders holding physical shares to convert them to electronic form, aligning with SEBI's broader dematerialisation initiative.